Published in Cardiovascular Business Week, July 12th, 2005
Cao and Striffler join the company's scientific research team in order to accelerate ongoing studies of the beneficial effects of cinnamon on insulin and diabetes, and in accordance with the company's cooperative research and development agreement (CRADA) with the U.S. Department of Agriculture's (USDA) agricultural research service (ARS).
Working within the terms of the CRADA agreement, Cao and Striffler will actively pursue PhytoMedical's research initiatives under the auspices of widely published chromium and insulin expert, Dr. Richard A....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week